News | Mammography | April 04, 2017

Five-year study employed Kubtec’s Mozart System with TomoSpec technology

digital breast tomosynthesis, DBT, 3-D mammography, breast imaging, re-excision rate, breast surgeries, ECR 2017, Kubtec Mozart System

April 4, 2017 — A study presented at the 2017 European Congress of Radiology (ECR) has concluded that adding digital breast tomosynthesis (DBT) is emerging as promising technology for surgical planning, as it offers a better view of lesion margins than mammography alone. The study results were presented at ECR 2017, March 1-5 in Vienna, Austria, by Alessia Milan, Ph.D., from the University of Turin.

The five-year study of 925 breast cancer patients demonstrated that the use of DBT can reduce re-excision rates by up to 50 percent.

"Margin status is one of the most important predictors for local recurrence following breast cancer surgery, and accurate pre-operative staging helps to plan appropriate surgical treatment and reduce the consequences of re-excision," Milan told meeting attendees. "These consequences can include emotional burden for the patient, a worse cosmetic outcome and higher costs."

The latest tool to use digital tomosynthesis to drive a reduction in positive margins is the Mozart System with TomoSpec Technology from Kubtec. The company said it is the first and only 3-D specimen tomosynthesis system designed specifically for intraoperative use.

Rather than producing a single 2-D planar view of multiple tissue layers, the Mozart System uses 3-D tomosynthesis technology to eliminate tissue interference by digitally removing overlying or underlying tissue in 1mm slices. This means that potential extensions of the cancer, radiating laterally or deep to the lesion, can be seen with greater clarity, helping to decrease the risk of positive margins and optimizing the cosmetic outcome of the procedure.

The Mozart System uses digital tomosynthesis to provide a three-dimensional solution to a three-dimensional problem during the treatment stage of breast cancer.

For more information: www.kubtec.com


Related Content

News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
Subscribe Now